Literature DB >> 2866085

On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor.

S Conway, S M McCann, L Krulich.   

Abstract

To determine the role of somatostatin (SRIF) and GH-releasing factor (GRF) in GH autofeedback, 20 micrograms rat GH in 2 microliter were injected into the third ventricle (IVT) 1 or 3 h before injection of the alpha 2-receptor stimulator clonidine (50 micrograms/kg, iv), which elevates plasma GH and TSH levels in normal rats. GH preinjected 1 or 3 h before clonidine significantly suppressed the clonidine-induced GH surge, whereas TSH release was not affected by GH. Preinjection of ovine LH IVT following the same protocol did not inhibit the clonidine-induced GH surge, suggesting a specific effect of IVT GH. Passive immunization with 400 microliters sheep antisomatostatin serum did not reverse the inhibition of the clonidine-induced GH surge by exogenous GH administered IVT either 1 or 3 h before clonidine. The TSH response was augmented by this procedure. Furthermore, IVT GH did not reduce the surges of GH and TSH elicited by GRF (250 ng/kg, iv) and TRH (150 ng/kg, iv) administered 1 or 3 h after IVT rat GH. These results suggest that GH autofeedback is mediated by reduced GRF secretion, rather than enhanced SRIF release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866085     DOI: 10.1210/endo-117-6-2284

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Gender modulates sequential suppression and recovery of pulsatile growth hormone secretion by physiological feedback signals in young adults.

Authors:  Johannes D Veldhuis; Leon Farhy; Arthur L Weltman; Jonathan Kuipers; Judith Weltman; Laurie Wideman
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

3.  Effect of growth hormone on short normal children.

Authors:  P C Hindmarsh; C G Brook
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

4.  Ghrelin reduces voltage-gated calcium currents in GH₃ cells via cyclic GMP pathways.

Authors:  Xuefeng Han; Yunlong Zhu; Yufeng Zhao; Chen Chen
Journal:  Endocrine       Date:  2011-08-27       Impact factor: 3.633

5.  Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathways.

Authors:  Xue Feng Han; Yun Long Zhu; Maria Hernandez; Damien J Keating; Chen Chen
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

6.  Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adebordurin M Adeniji; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

7.  GH3 cell secretion of growth hormone and prolactin increases spontaneously during perifusion.

Authors:  C A Lapp; M E Stachura; J M Tyler; Y S Lee
Journal:  In Vitro Cell Dev Biol       Date:  1987-10

8.  Physiological levels of growth hormone fail to suppress growth hormone releasing hormone (1-29) NH2-stimulated growth hormone secretion in man.

Authors:  C Brain; D N Thakrar; P C Hindmarsh; C G Brook
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

9.  Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons.

Authors:  I Ganzetti; F Petraglia; I Capuano; F Rosi; W B Wehrenberg; E E Müller; D Cocchi
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

10.  Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.

Authors:  I Gil-Ad; B Klinger; A Pertzelan; B Erster; A Silbergeld; H Talpaz; Z Laron
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.